JD Health International (HKSE:06618) ROE % Adjusted to Book Value : 1.03% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International ROE % Adjusted to Book Value?

JD Health International's ROE % for the quarter that ended in Dec. 2023 was 2.37%. JD Health International's PB Ratio for the quarter that ended in Dec. 2023 was 2.31. JD Health International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 1.03%.

JD Health International ROE % Adjusted to Book Value Historical Data

The historical data trend for JD Health International's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International ROE % Adjusted to Book Value Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.70

-0.68

0.19

1.95

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-0.78	0.27	0.15	2.24	1.03

Competitive Comparison of JD Health International's ROE % Adjusted to Book Value

For the Medical Care Facilities subindustry, JD Health International's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JD Health International's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where JD Health International's ROE % Adjusted to Book Value falls into.

JD Health International ROE % Adjusted to Book Value Calculation

JD Health International's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	4.51%	/	2.31
	=	1.95%

JD Health International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.37%	/	2.31
	=	1.03%

JD Health International ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of JD Health International's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

Executives

Liu Qiangdong Richard	2101 Beneficial owner
Jd Jiankang Limited	2101 Beneficial owner
Jd.com, Inc.	2201 Interest of corporation controlled by you

JD Health International (HKSE:06618) Headlines

No Headlines